PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Niagen Bioscience, Inc.
Filed: April 23, 2010
Period of Report: May 20, 2010
Accession Number: 0001193125-10-091940

View Document ↗ View on SEC.gov ↗